Harmony Biosciences, LLC et al v. MSN Pharmaceuticals Inc. et al
| Harmony Biosciences, LLC, Bioprojet Socite Civile de Recherche and Bioprojet Pharma SAS |
| MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited |
| 1:2023cv01420 |
| December 11, 2023 |
| US District Court for the District of Delaware |
| Jennifer L Hall |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 2, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 20 Letter to The Honorable Jennifer L. Hall from Jeremy A. Tigan regarding Joint Status Report. (Tigan, Jeremy) Modified on 2/2/2024 (ceg). |
Filing 19
ORAL ORDER: Having reviewed the January 17, 2024 letter (No. 23-1420, D.I. 18), IT IS ORDERED that, on or before February 2, 2024, the parties shall meet and confer and file a joint status report regarding how the Court should proceed with these actions (including the pending Motion to Dismiss (No. 23-1420, D.I. 9)). Ordered by Judge Jennifer L. Hall on 1/19/2024. Associated Cases: 1:23-cv-01420-JLH, 1:24-cv-00048-JLH(ceg)
|
| Filing 18 Letter to The Honorable Jennifer L. Hall from Jeremy A. Tigan regarding related action transferred from E.D. Va. (Attachments: #1 Exhibit A)(Tigan, Jeremy) |
| CORRECTING ENTRY: The pdf for the Reply Brief found at D.I. 17 has been replaced with a corrected version per counsel's request. (ceg) |
| Filing 17 REPLY BRIEF re #9 MOTION to Dismiss Based upon Under the First to File Rule filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: #1 Exhibit I, #2 Exhibit J, #3 Exhibit K, #4 Exhibit L, #5 Exhibit M, #6 Exhibit N, #7 Exhibit O, #8 Exhibit P, #9 Exhibit Q, #10 Exhibit R, #11 Exhibit S, #12 Exhibit T)(Weinblatt, Richard) (Main Document 17 replaced on 1/11/2024) (ceg). |
|
SO ORDERED re #15 MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. ORDERED by Judge Maryellen Noreika on 1/9/2024. (dlw)
|
| Pro Hac Vice Attorneys Ronald M. Daignault and Richard Juang for MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Case Reassigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:23-cv-01286-JLH, 1:23-cv-01340-JLH, 1:23-cv-01420-JLH (rjb) |
| Filing 16 Pro Hac Vice Fee - Credit Card Payment received for Ronald M. Daignault and Richard Juang. ( re #15 MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang )( Payment of $ 100, receipt number ADEDC-4309449).(Weinblatt, Richard) |
| Filing 15 MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Weinblatt, Richard) |
|
SO ORDERED re #14 STIPULATION TO EXTEND TIME to Answer the Complaint to February 29, 2024 (Set/Reset Answer Deadlines: MSN Laboratories Private Limited answer due 2/29/2024; MSN Pharmaceuticals Inc. answer due 2/29/2024). ORDERED by Judge Maryellen Noreika on 1/5/2024. (dlw)
|
| Filing 14 STIPULATION TO EXTEND TIME to Answer the Complaint to February 29, 2024 - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Weinblatt, Richard) |
| Filing 13 ANSWERING BRIEF in Opposition re #9 MOTION to Dismiss Based upon Under the First to File Rule filed by Bioprojet Pharma SAS, Bioprojet Socite Civile de Recherche, Harmony Biosciences, LLC.Reply Brief due date per Local Rules is 1/10/2024. (Attachments: #1 Ex. 1, #2 Ex. 2)(Tigan, Jeremy) |
|
SO ORDERED re #12 MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, Sarahi Uribe, Elaine H. Nguyen, Pierre Anquetil and Yiye Fu of COVINGTON & BURLING LLP filed by Harmony Biosciences, LLC, Bioprojet Pharma SAS, Bioprojet Socite Civile de Recherche. ORDERED by Judge Maryellen Noreika on 1/2/2024. (dlw)
|
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, Sarahi Uribe, Elaine H. Nguyen, Pierre Anquetil and Yiye Fu of COVINGTON & BURLING LLP - filed by Bioprojet Pharma SAS, Bioprojet Socite Civile de Recherche, Harmony Biosciences, LLC. (Tigan, Jeremy) |
| Filing 11 SUMMONS Returned Executed by Harmony Biosciences, LLC, Bioprojet Socite Civile de Recherche, Bioprojet Pharma SAS.MSN Laboratories Private Limited served on 12/15/2023, answer due 1/5/2024. (Blumenfeld, Jack) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Pvt. Ltd. for MSN Pharmaceuticals Inc. filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Weinblatt, Richard) |
| Filing 9 MOTION to Dismiss Based upon Under the First to File Rule - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Text of Proposed Order)(Weinblatt, Richard) |
| Filing 8 SUMMONS Returned Executed by Harmony Biosciences, LLC, Bioprojet Socite Civile de Recherche, Bioprojet Pharma SAS.MSN Pharmaceuticals Inc. served on 12/14/2023, answer due 1/4/2024. (Blumenfeld, Jack) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Filing 7 Summons Issued as to MSN Laboratories Private Limited on 12/11/2023; MSN Pharmaceuticals Inc. on 12/11/2023. (Attachments: #1 Summons Issued MSN Pharmaceuticals Inc.)(jfm) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bioproject Societe Civile de Recherche for Bioprojet Pharma SAS filed by Bioprojet Pharma SAS, Bioprojet Socit Civile de Recherche. (jfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Harmony Biosciences Holdings, Inc. for Harmony Biosciences, LLC filed by Harmony Biosciences, LLC. (jfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,486,947 B2; 8,207,197 B2; 8,354,430 B2. (jfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Plaintiffs are still investigating the date notice was received. Date of Expiration of Patent: U.S. Patent No. 8,486,947 expires on September 26, 2029; U.S. Patent No. 8,207,197 expires on March 7, 2030; U.S. Patent No. 8,354,430 expires on February 6, 2026.Thirty Month Stay Deadline: 2/14/2027. (jfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Filing fee $ 405, receipt number ADEDC-4292296.) - filed by Harmony Biosciences, LLC, Bioprojet Socite Civile de Recherche, Bioprojet Pharma SAS. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(jfm). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
